Lack of association of angiotensin-converting enzyme insertion/deletion polymorphism and myocardial infarction at very young ages

References

• Acarturk E, Attila G, Bozkurt A, Akpinar O, Matyar S, Seydaoglu G. (2005). Insertion/deletion polymorphism of the angiotensin converting enzyme gene in coronary artery disease in southern Turkey. J Biochem Mol Biol 38:486–90.
   PubMedGoogle Scholar
• Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A. (2000). ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol 20:484–92.
   PubMed Web of Science ®Google Scholar
• Andrikopoulos GK, Richter DJ, Needham EW, et al. (2004). The paradoxical association of common polymorphisms of the renin–angiotensin system genes with risk of myocardial infarction. Eur J Cardiovasc Prev Rehabil 11:477–83.
   PubMedGoogle Scholar
• Araújo MA, Goulart LR, Cordeiro ER, et al. (2005). Genotypic interactions of renin–angiotensin system genes in myocardial infarction. Int J Cardiol 103:27–32.
   PubMed Web of Science ®Google Scholar
• Bautista LE, Ardila ME, Gamarra G, Vargas CI, Arenas IA. (2004). Angiotensin-converting enzyme gene polymorphism and risk of myocardial infarction in Colombia. Med Sci Monit 10:473–9.
   Web of Science ®Google Scholar
• Berdeli A, Sekuri C, Sirri Cam F, et al. (2005). Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population. Clin Chim Acta 351:87–94.
   PubMed Web of Science ®Google Scholar
• Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE. (1998). Effect of activation and inhibition of the renin–angiotensin system on plasma PAI-1. Hypertension 32:965–71.
   PubMed Web of Science ®Google Scholar
• Cambien F, Poirier O, Lecerf L, et al. (1992). Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641–4.
   PubMed Web of Science ®Google Scholar
• Choudhury I, Marsh JD. (1999). Myocardial infarction in young patients. Am J Med 107:254–61.
   PubMed Web of Science ®Google Scholar
• Covolo L, Gelatti U, Metra M, Donato F, Nodari S, Pezzali N, Dei Cas L, Nardi G. (2003). Angiotensin-converting-enzyme gene polymorphism and heart failure: a case–control study. Biomarkers 8:429–36.
   PubMed Web of Science ®Google Scholar
• Huber K, Christ G, Wojta J, Gulba D. (2001). Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001. Thromb Res 103:S7–19.
   Web of Science ®Google Scholar
• Kim DK, Kim JW, Kim S, et al. (1997). Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 17:3242–7.
   PubMed Web of Science ®Google Scholar
• Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH. (1995). Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 91:2120–4.
   PubMed Web of Science ®Google Scholar
• Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. (1994). Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330:1041–6.
   PubMed Web of Science ®Google Scholar
• Methot J, Hamelin BA, Bogaty P, Arsenault M, Plante S, Poirier P. (2005). ACE-DD genotype is associated with occurrence of acute coronary syndrome in postmenopausal women. Int J Cardiol 105:308–14.
   PubMed Web of Science ®Google Scholar
• Mondry A, Loh M, Liu P, Zhu AL, Nagel M. (2005). Polymorphisms of the insertion/deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data. BMC Nephrol 6:1.
   PubMedGoogle Scholar
• Morshed M, Khan H, Akhteruzzaman S. (2002). Association between angiotensin I-converting enzyme gene polymorphism and hypertension in selected individuals of the Bangladeshi population. J Biochem Mol Biol 35:251–4.
   PubMedGoogle Scholar
• O’Donnell CJ, Lindpaintner K, Larson MG, et al. (1998). Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97:1766–22.
   PubMed Web of Science ®Google Scholar
• Petrovic D, Zorc M, Kanic V, Peterlin B. (2001). Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction. Angiology 52:247–52.
   PubMed Web of Science ®Google Scholar
• Pfohl M, Koch M, Prescod S, Haase KK, Haring HU, Karsh KR. (1999). Angiotensin I-converting enzyme gene polymorphism, coronary artery disease and myocardial infarction. An angiographically controlled study. Eur Heart J 1318–25.
   PubMedGoogle Scholar
• Rallidis LS, Belesi CI, Manioudaki HS, et al. (2003). Myocardial infarction under the age of 36: prevalence of thrombophilic disorders. Thromb Haemost 90:272–8.
   PubMed Web of Science ®Google Scholar
• Ramasawmy R, Manraj M, Kotea N, et al. (1996). Lack of association of angiotensin I-converting enzyme gene polymorphism and premature myocardial infarction in Mauritian Indians. Clin Genet 50:551–4.
   PubMed Web of Science ®Google Scholar
• Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–6.
   PubMed Web of Science ®Google Scholar
• Seckin D, Ilhan N, Ozbay Y. (2006). The relationship between ACE insertion/deletion polymorphism and coronary artery disease with or without myocardial infarction. Clin Biochem 39:50–4.
   PubMed Web of Science ®Google Scholar
• Sekuri C, Cam FS, Ercan E, et al. (2005). Renin–angiotensin system gene polymorphisms and premature coronary heart disease. JRAAS 6:38–42.
   Google Scholar
• van Bockxmeer FM, Mamotte CD, Burke V, Taylor RR. (2000). Angiotensin-converting enzyme gene polymorphism and premature coronary heart disease. Clin Sci (Lond) 99:247–51.
   PubMed Web of Science ®Google Scholar
• Vaughan DE, Lazos SA, Tong K. (1995). Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin–angiotensin system and thrombosis. J Clin Invest 95:995–1001.
   PubMed Web of Science ®Google Scholar
• Viitanen L, Pihlajamäki J, Halonen P, et al. (2001). Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease. Atherosclerosis 157:57–64.
   PubMed Web of Science ®Google Scholar
• Wesolowska E, Marcil M, Lussier-Cacan S, Davignon J, Latour Y, Genest J Jr. (1998). Angiotensin converting enzyme insertion/deletion polymorphism in French Canadian subjects with premature coronary artery disease. Pathol Biol (Paris) 46:295–300.
   PubMedGoogle Scholar
• Zimmerman FH, Cameron A, Fisher LD, Ng G. (1995). Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 26:654–61.
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Lau J. (2008). Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61:634–45.
   PubMed Web of Science ®Google Scholar
• Zintzaras E, Raman G, Kitsios G, Lau J. (2008). Angiotensin-converting enzyme insertion-deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med 168:1077–89.
   PubMedGoogle Scholar